JWH-051
Overview[edit | edit source]
JWH-051 is a synthetic cannabinoid that acts as a potent agonist at the CB1 receptor and CB2 receptor. It is part of the naphthoylindole family of compounds, which are known for their psychoactive properties. JWH-051 was developed in the 1990s by John W. Huffman and his team at Clemson University as part of research into the endocannabinoid system.
Chemical Structure[edit | edit source]
JWH-051 has the chemical formula C25H25NO2 and a molecular weight of 371.47 g/mol. Its structure includes a naphthoyl group attached to an indole core, which is a common feature among synthetic cannabinoids. The presence of a methoxy group on the naphthoyl moiety distinguishes it from other compounds in the JWH series.
Pharmacology[edit | edit source]
JWH-051 is a full agonist at both the CB1 and CB2 receptors, with a higher affinity for the CB1 receptor. This receptor is primarily located in the central nervous system, which explains the psychoactive effects of the compound. The CB2 receptor is found mainly in the immune system, and its activation is associated with anti-inflammatory effects.
Mechanism of Action[edit | edit source]
The activation of CB1 receptors by JWH-051 leads to the inhibition of adenylate cyclase, resulting in decreased levels of cyclic AMP (cAMP). This cascade of events ultimately affects neurotransmitter release, leading to the compound's psychoactive effects.
Legal Status[edit | edit source]
Due to its psychoactive properties, JWH-051 is classified as a controlled substance in many countries. It is often included in legislation targeting synthetic cannabinoids, which are sometimes sold as "spice" or "K2".
Safety and Toxicity[edit | edit source]
The safety profile of JWH-051 is not well-documented, as it was primarily developed for research purposes. However, synthetic cannabinoids, in general, have been associated with adverse effects such as tachycardia, hypertension, hallucinations, and psychosis.
Related Compounds[edit | edit source]
JWH-051 is part of a larger group of synthetic cannabinoids, including JWH-018, JWH-073, and JWH-200. These compounds share similar structures and pharmacological profiles but differ in their potency and receptor selectivity.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
